Promethazine, sold under the brand name Phenergan among others, is a first-generation antihistamine, sedative, and antiemetic used to treat allergies, nausea, and vomiting. It may also help with some symptoms associated with the common cold and may also be used for sedating people who are agitated or anxious, an effect that has led to some recreational use (especially with codeine). Promethazine is taken by mouth (oral), as a rectal suppository, or by injection into a muscle (IM). Common side effects of promethazine include confusion and sleepiness; consumption of alcohol or other sedatives can make these symptoms worse. It is unclear if use of promethazine during pregnancy or breastfeeding is safe. Use of promethazine is not recommended in those less than two years old, due to potentially negative effects on breathing. Use of promethazine by injection into a vein is not recommended, due to potential skin damage. Promethazine is in the phenothiazine family of medications. It is also a strong anticholinergic and at high or toxic doses can act as a deliriant. Promethazine was made in the 1940s by a team of scientists from Rhône-Poulenc laboratories. It was approved for medical use in the United States in 1951. It is a generic medication and is available under many brand names globally. In 2023, it was the 230th most commonly prescribed medication in the United States, with more than 1 million prescriptions; and the combination with dextromethorphan was the 252nd most commonly prescribed medication in the United States, with more than 1 million prescriptions.
Medical uses
Promethazine has a variety of medical uses, including:
Sedation In Germany, it is approved for the treatment of agitation and agitation associated with underlying psychiatric disorders with a maximum daily dose of 200 mg. For nausea and vomiting associated with anesthesia or chemotherapy. It is commonly used postoperatively as an antiemetic. The antiemetic activity increases with increased dosing; however, side effects also increase, which often limits maximal dosing. For moderate to severe morning sickness and hyperemesis gravidarum: In the UK, promethazine is the drug of first choice. Promethazine is preferred during pregnancy because it is an older drug and there is more data regarding the use of it during pregnancy. Second-choice medications, which are used if promethazine is not tolerated or the patient cannot take it, are metoclopramide or prochlorperazine. For allergies such as hay fever and together with other medications in anaphylaxis To aid with symptoms of the common cold Motion sickness, including space sickness Hemolytic disease of the newborn Anxiety before surgery May be used to treat cannabinoid hyperemesis syndrome
Side effects Some documented side effects include:
Tardive dyskinesia, pseudoparkinsonism, acute dystonia (effects due to dopamine D2 receptor antagonism) Confusion in the elderly Drowsiness, dizziness, fatigue, more rarely vertigo Known to have effects on serotonin and dopamine receptors. Dry mouth Nausea Respiratory depression in patients under the age of two and those with severely compromised pulmonary function Blurred vision, xerostomia, dry nasal passages, dilated pupils, constipation, and urinary retention. (due to its anticholinergic effects) Chest discomfort/pressure (In children less than 2 years old) Akathisia Less frequent:
Cardiovascular side effects to include arrhythmias and hypotension Neuroleptic malignant syndrome Liver damage and cholestatic jaundice Bone marrow suppression, potentially resulting in agranulocytosis, thrombocytopenia, and leukopenia Depression of the thermoregulatory mechanism resulting in hypothermia/hyperthermia Rare side effects include:
Seizures Because of the potential for more severe side effects, this drug is on the list to avoid in the elderly. In many countries (including the US and UK), promethazine is contraindicated in children less than two years of age, and strongly cautioned against in children between two and six, due to problems with respiratory depression and sleep apnea. Promethazine is listed as one of the drugs with the highest anticholinergic activity in a study of anticholinergic burden, including long-term cognitive impairment.
Tissue necrosis risks specific to the injectable form Injectable promethazine is a vesicant and is capable of damaging blood vessel intima, potentially resulting in tissue injury and gangrene. A large number of severe complications have been reported following inadvertent arterial injection, subcutaneous injection, or extravasation of promethazine, including the amputation of fingers and a forearm. One lawsuit reached the Supreme Court of the United States and resulted in $6.7 million in damages. Severe injuries resulting from inadvertent arterial injections of promethazine have been known since at least the 1970s. When injectable promethazine must be used, the Institute for Safe Medication Practices recommends limiting the dose to between 6.25 mg or 12.5 mg, using central access sites and large veins, administering the drug slowly, or resorting to safer options.
Overdose Promethazine in overdose can produce signs and symptoms including CNS depression, hypotension, respiratory depression, unconsciousness, and sudden death. Other reactions may include hyperreflexia, hypertonia, ataxia, athetosis, and extensor-plantar reflexes. Atypically and/or rarely, stimulation, convulsions, hyperexcitability, and nightmares may occur. Anticholinergic effects, like dry mouth, dilated pupils, flushing, gastrointestinal symptoms, and delirium, may occur as well. Treatment of overdose is supportive and based on symptoms.
… excerpt ends here. Continue reading the full article.





